400 Alexander Park Drive, Suite 301, Princeton, California, 08540, United States
Developing first-in-class p53 modulators for cancer treatment.
Total Raised
$174 M
Rounds
3
Links
Verticals
Series D
Aug 2020
$70M
Series B
Feb 2017
$74M
Series A
Dec 2014
$30M
David H. Mack
Co-Founder, President & CEO
Thomas Shenk
Co-Founder & Member, Scientific Advisory Board
Arnold Levine
Co-Founder
Tim Smith
SVP, Head of Corporate Development
